Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

NCT00454987 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

288

Enrollment

INDUSTRY

Sponsor class

Conditions

Haemophilus Influenzae Type b
Neisseria Meningitidis
Neisseria Meningitidis-Haemophilus Influenzae Type b Vaccine

Interventions

BIOLOGICAL: Menitorix
BIOLOGICAL: Infanrix IPV

Sponsor

GlaxoSmithKline